Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Robins HI, Katschinski DM, Longo W, Grosen E, Wilding G, Gillis W, Kraemer C, Tiggelaar CL, Rushing D, Stewart JA, Spriggs D, Love R, Arzoomanian RZ, Feierabend C, Alberti D, Morgan K, Simon K, d'Oleire F. Robins HI, et al. Among authors: d oleire f, spriggs d. Cancer Chemother Pharmacol. 1999;43(5):409-14. doi: 10.1007/s002800050915. Cancer Chemother Pharmacol. 1999. PMID: 10100597
Cytokine induction by 41.8 degrees C whole body hyperthermia.
Robins HI, Kutz M, Wiedemann GJ, Katschinski DM, Paul D, Grosen E, Tiggelaar CL, Spriggs D, Gillis W, d'Oleire F. Robins HI, et al. Among authors: d oleire f, spriggs d. Cancer Lett. 1995 Nov 6;97(2):195-201. doi: 10.1016/0304-3835(95)03976-4. Cancer Lett. 1995. PMID: 7497463
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA. Robins HI, et al. Among authors: d oleire f, spriggs d. J Clin Oncol. 1997 Jan;15(1):158-64. doi: 10.1200/JCO.1997.15.1.158. J Clin Oncol. 1997. PMID: 8996137 Clinical Trial.
361 results